Article

Management and conduct of randomized controlled trials.

Maryland Medical Research Institute, 600 Wyndhurst Avenue, Baltimore, MD 21210, USA.
Epidemiologic Reviews (Impact Factor: 9.27). 02/2002; 24(1):12-25.
Source: PubMed

ABSTRACT In preparing to undertake a clinical trial, it may be helpful to keep in mind Fredrickson's description of clinical trials (31): "Field trials are indispensable. They will continue to be an ordeal. They lack glamour, they strain our resources and patience, and they protract the moment of truth to excruciating limits. Still, they are among the most challenging tests of our skills. I have no doubt that when the problem is well chosen, the study is appropriately designed, and that when all the populations concerned are made aware of the route and the goal, the reward can be commensurate with the effort. If, in major medical dilemmas, the alternative is to pay the costs of perpetual uncertainty, have we really any choice?"

0 Bookmarks
 · 
52 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: This chapter reviews and discusses essential elements of designing and conducting clinical research that lead to successful reporting of clinical trial results in renal transplantation. The authors highlight key considerations in designing a clinical study that evaluates the safety and efficacy of a theoretical novel immunosuppressive agent, as well as in execution of such a study. KeywordsEndpoints-Analysis-Clinical trials-Immunosuppression-Study protocol
    11/2010: pages 139-153;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: SummAry According to epidemiologic reports, the harmful use of alcohol and illicit drugs has increased among the Mexican population. This use is associated to several risks and issues that affect public health and the public well-being of the country. In this article it is acknowledged the need for development of treatment models and interventions whose therapeutic value is demonstrated by scientific evidence, that respond to the attention needs of the population affected by sub-stance use in our country and that can be generalized in community clinical practice. In clinical research, randomized controlled clinical trials (RCT's) are the "gold standard" to demonstrate the effect of a therapeutic intervention. A randomized controlled clinical trial is a prospective study in which the effect, value and safety of one or various experi-mental interventions are tested against a "control" intervention in hu-man subjects. Acknowledging that in Mexico there is a lack of research on addiction treatment that is compliant with all the requirements to be considered as an RCT, this article presents some methodological and ethical considerations that are neccesary for their design and conduc-tion. These considerations include from the establishment of a relevant research question and objectives, adequate study design, develop-ment of strategies for data management, statistical analysis, monitor-ing of interventions, safety monitoring and research quality assurance and protection of human subjects.
    Salud Mental 01/2013; 36:253-265. · 0.42 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Good clinical practice (GCP) guidelines emphasize trial site monitoring, although the implementation is unspecified and evidence for benefit is sparse. We aimed to develop a site monitoring process using peer reviewers to improve staff training, site performance, data collection, and GCP compliance. The Peer Review Intervention for Monitoring and Evaluating sites (PRIME) team observed and gave feedback on trial recruitment and follow-up appointments, held staff meetings, and examined documentation during annual 2-day site visits. The intervention was evaluated in the ProtecT trial, a UK randomized controlled trial of localized prostate cancer treatments (ISRCTN20141297). The ProtecT coordinator and senior nurses conducted three monitoring rounds at eight sites (2004-2007). The process evaluation used PRIME report findings, trial databases, resource use, and a site nurse survey. Adverse findings decreased across all sites from 44 in round 1 to 19 in round 3. Most findings related to protocol adherence or site organizational issues, including improvements in eligibility criteria application and data collection. Staff found site monitoring acceptable and made changes after reviews. The PRIME process used observation by peer reviewers to improve protocol adherence and train site staff, which increased trial performance and consistency.
    Journal of clinical epidemiology 01/2011; 64(6):628-36. · 5.33 Impact Factor

Full-text

View
0 Downloads
Available from